×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
📊
Experiments
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
🎯
Targets
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
💹
Economics
📊
Experiments
🤖
Agents
🚦
Status
📑
Docs
Pantheon
🎭
Personas
🏛
Pantheon
📜
Commands
🤖
Agents Directory
Showcase
⭐
Showcase
📽
Demo
ℹ
Vision
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Experiments
Agora
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Targets
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Economics
Status
Pantheon
▼
Personas
Pantheon
Commands
Agents Directory
Showcase
▼
Showcase
Demo
Vision
←
Home
/
Wiki
/
Clinical: Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Latera
clinical
4,511 words
KG: rapamycin
Contents
Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Lateral Sclerosis
No AI portrait yet
Generate portrait ✦
Knowledge Graph
Knowledge Graph (12 edges)
rapamycin
inhibits
MTORC1
rapamycin
inhibits
mTOR
rapamycin
treats
seizures
rapamycin
activates
autophagy
rapamycin
treats
stroke
rapamycin
inhibits
MTOR
rapamycin
prevents
aging
rapamycin
activates
PARKIN
rapamycin
targets
RUBCN
rapamycin
targets
ATG
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)
Community Feedback
⬆ Upvote
0
⬇ Downvote
0 upvotes · 0 downvotes
Post Comment
⚠ Flag Error
✏ Suggest Edit
💬 0 comments
⚠ 0 flags
✏ 0 edit suggestions
No comments yet. Be the first to comment!
View all feedback (JSON)